Influenza

Lancet

Volumn 354, Issue 9186, 1999, Pages 1277-1282

  Cox, Nancy J ^a   Subbarao, Kanta ^a  

^a NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; ANTIVIRUS AGENT; INFLUENZA VACCINE; LIVE VACCINE; OSELTAMIVIR; RIMANTADINE; SIALIDASE; SIALIDASE INHIBITOR; UNCLASSIFIED DRUG; ZANAMIVIR;

ACUTE RESPIRATORY TRACT DISEASE; CLINICAL PRACTICE; CLINICAL TRIAL; COMPLICATION; DIAGNOSTIC TEST; DISEASE CONTROL; HIGH RISK POPULATION; HUMAN; INFLUENZA; INFLUENZA VIRUS A; INFLUENZA VIRUS B; INHALATIONAL DRUG ADMINISTRATION; INTRANASAL DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RECURRENT DISEASE; REVIEW;

EID: 0033539297     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(99)01241-6     Document Type: Review

References (47)

1. Barker W.H., Mullooly J.P. Pneumonia and influenza deaths during epidemics: implications for prevention. Arch Intern Med. 142:1982;85-89.
2. Simonsen L, Clarke M.J., Williamson G.D., Stroup D.F., Arden N.H., Schonberger L.B. The impact of influenza epidemics on mortality: introducing a severity index. Am J Public Health. 87:1997;1944-1950.
3. Virus taxonomy. Seventh Report of the International Committee on Taxonomy of viruses. New York: Academic Press (in press).
4. Webster R.G., Bean W.J., Gorman O.T., Chambers T.M., Kawaoka Y. Evolution and ecology of influenza A viruses. Microbiol Rev. 56:1992;152-179.
5. Smith W., Andrewes C.H., Laidlaw P.P. A virus obtained from influenza patients. Lancet. i:1933;66-68.
6. Moser M.R., Bender T.R., Margolis H.S., Noble G.R., Kendal A.P., Ritter D.G. An outbreak of influenza aboard a commercial airliner. Am J Epidemiol. 110:1979;1-6.
7. Nicholson K.G Human influenza. Nicholson K.G., Hay A.J., Webster R.G. Textbook of influenza. 1998;222 Blackwell Science, Boston.
8. Wright P.F., Ross K.B., Thompson J., Karzon D.T. Influenza A infections in young children. N Engl J Med. 296:1977;829-834.
9. Parrot R.H., Kim H.W., Vargosko A.J., Chanock R.M. Serious respiratory tract illness as a result of Asian influenza and influenza B infections in children. J Pediatr. 61:1962;205-213.
10. Kerr A.A., Downham M.A.P.S., McQuillin J., Gardner P.S. Gastric 'flu influenza B causing abdominal symptoms in children. Lancet. i:1957;291-295.
11. Price D.A., Postlethwaite R.J., Longson M. Influenzavirus A2 infections presenting with febrile convulsions and gastrointestinal symptoms in young children. Clin Pediatr. 15:1976;362-367.
12. Paisley J.W., Bruhn F.W., Lauer B.A., McIntosh K. Type A2 influenza viral infections in children. Am J Dis Child. 132:1978;34-36.
13. Bennett N.M.c.K. Diagnosis of influenza. Med J Aust. i:1973;19-22.
14. Woodall J., Rowson K.E.K., McDonald J.C. Age and Asian influenza, 1957. BMJ. iv:1958;1316-1318.
15. Wright P.F., Bryant J.D., Karzon D.T. Comparison of influenza B/Hong Kong virus infections among infants, children, and young adults. J Infect Dis. 141:1980;430-435.
16. Dagan R., Hall C.B. Influenza A virus infection imitating bacterial sepsis in early infancy. Pediatr Infect Dis J. 3:1984;218-221.
17. Sanders D.Y., Carroll N.B., Jeffreys L.U., Vick S.S. Outbreak of influenza A2 (Hong Kong strain) in a children's home. South Med J. 63:1970;413-416.
18. Saenz A.C., Assaad F.A., Cockburn W.C. Outbreak of A2/Hong Kong/68 influenza at an international medical conference. Lancet. i:1969;91-93.
19. Blumenfeld H.L., Lilbourne E.D., Louria D.B., Rogers D.E. Studies in influenza in the pandemic of 1957-1958, I: an epidemiologic, clinical and serologic investigation of an intrahospital epidemic, with a note on vaccination efficacy. J Clin Invest. 38:1959;199-212.
20. Falsey A.R., Cunningham C.K., Barker W.H.et al. Respiratory syncytial virus and influenza A infections in the hospitalized elderly. J Infect Dis. 172:1995;389-394.
21. Ryan Poirier K.A. Influenza virus infection in children. Adv Pediatr Infect Dis. 10:1995;125-156.
22. Noble G.R. Epidemiological and clinical aspects of influenza. Beare A.S. Basic and applied influenza research. 1982;11-50 CRC Press, Boca Raton.
23. Neuzil K.M., Reed G.W., Mitchel E.F., Simonsen L., Griffin M.R. Impact of influenza on acute cardiopulmonary hospitalizations in pregnant women. Am J Epidemiol. 148:1998;1094-1102.
24. Yuen K.Y, Chan P.K.S., Peiris M.et al. Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus. Lancet. 351:1998;467-471.
25. Carilli A.D., Gohd R.S., Gordon W. A virologic study of chronic bronchitis. N Engl J Med. 270:1964;123-127.
26. Ferson M.J., Morton J.R., Robertson P.W. Impact of influenza on morbidity in children with cystic fibrosis. J Paediatr Child Health. 27:1991;308-311.
27. Minor M.E., Dick E.C., Baker J.W., Ouellette J.J., Cohen M., Reed C.E. Rhinovirus and influenza A infections as precipitants of asthma. Am Rev Respir Dis. 113:1976;149-153.
28. Fujimoto S., Kobayashi M., Uemura O.et al. PCR on cerebrospinal fluid to show influenza-associated acute encephalopathy or encephalitis. Lancet. 352:1998;873-875.
29. McCullers J.A., Facchini S., Chesney P.J., Webster R.G. Influenza B virus encephalitis. Clin Infect Dis. 28:1999;898-900.
30. MacDonald K.L., Osterholm M.T., Hedberg C.W.et al. Toxic shock syndrome: a newly recognized complication of influenza and influenza-like illness. JAMA. 257:1987;1053-1058.
31. Stockton J., Ellis J.S., Saville M., Clewley J.P., Zambon M.C. Multiplex PCR for typing and subtyping influenza and respiratory syncytial viruses. J Clin Microbiol. 36:1998;2990-2995.
32. Potter C.W., Oxford J.S. Determinants of immunity to influenza infection in man. Br Med Bull. 35:1979;69-75.
33. Heikkinen T., Ruuskanen O., Waris M., Ziegler T., Arola M., Halonen P. Influenza vaccination in the prevention of acute otitis media in children. Am J Dis Child. 145:1991;445-448.
34. Nichol K.L., Lind A., Margolis K.L., Murdoch M., McFadden R., Hauge M.et al. The effectiveness of vaccination against influenza in healthy, working adults. N Engl J Med. 333:1995;889-893.
35. Nichol K.L., Margolis K.L., Wuorenma J., Von Sternberg T. The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. N Engl J Med. 331:1994;778-784.
36. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP), Centers for Disease Control and Prevention. MMWR Morb Mortal Wkly Rep. 47:1998;1-26.
37. James J.M., Zeiger R.S., Lester M.R.et al. Safe administration of influenza vaccine to patients with egg allergy. J Pediatr. 133:1998;624-628.
38. Lasky T., Terracciano G.J., Magder L.et al. The Guillain-Barré syndrome and the 1992-93 and 1993-94 influenza vaccines. N Engl J Med. 339:1998;1797-1802.
39. Murphy B.R. Use of live attenuated cold-adapted influenza A ressortant virus vaccines in infants, young adults, and elderly adults. Infect Dis Clin Pract. 2:1993;174-181.
40. Belshe R.B., Mendelman P.M., Treanor J.et al. The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children. N Engl J Med. 338:1998;1405-1412.
41. Nichol K.L., Mendelman P.M., Mallon K.P. Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults: a randomized controlled trial. JAMA. 282:1999;137-144.
42. Hayden F.G., Osterhaus A.D.M.E., Treanor J.J.et al. Efficacy and safety of the neuraminidase inhibitor zanamavir in the treatment of influenzavirus infections. N Engl J Med. 337:1997;874-880.
43. Efficacy and safety of inhaled zanamavir in the treatment of influenza A and B virus infections. Lancet. 352:1998;1877-1881.
44. Monto A.S., Fleming D.M., Henry D.et al. Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenza A and B virus infections. J Infect Dis. 180:1999;254-261.
45. Monto A.S., Robinson D.P., Herlocher M.L., Hirson J.M. Jr., Elliott M.J., Chrisp A. Zanamivir in the prevention of influenza among healthy adults: a randomized controlled trial. JAMA. 282:1999;31-35.
46. Hayden FG, Treanor JJ, Huson L, Ward P, Wegmueller Y, Mills RG. Oral GS4104 treatment of acute influenza benefits health and activity measures. Abstract 790. Infectious Diseases Society of America, Denver, CO, USA. November 1998.
47. Gubareva L.V., Matrosovich M.N., Brenner M.K., Bethell R.C., Webster R.G. Evidence for zanamavir resistance in an immunocompromised child infected with influenza B virus. J Infect Dis. 178:1998;1257-1262.